Alzheimer's disease

FILE - In this Aug. 14, 2018 file photo, a doctor looks at a PET brain scan at the Banner Alzheimers Institute in Phoenix. Two experimental drugs failed to prevent or slow mental decline in a study of people who are virtually destined to develop Alzheimer's disease at a relatively young age because of rare gene flaws. The results announced Monday, Feb. 10, 2020, are another disappointment for the approach that scientists have focused on for many years -- trying to remove a harmful protein that builds up in the brains of people with the disease. (AP Photo/Matt York, File)
February 10, 2020 - 8:04 am
Two experimental drugs failed to prevent or slow mental decline in a study of people who are virtually destined to develop Alzheimer's disease at a relatively young age because they inherited rare gene flaws. The results announced Monday are another disappointment for the approach that scientists...
Read More
Charles Flagg, who is stricken with Alzheimer's disease, sits for an infusion while participating in a study on the drug Aducanumab at Butler Hospital in Providence, R.I. New results were released on the experimental medicine whose maker claims it can slow the decline of Alzheimer's disease, the most common form of dementia. (AP Photo/Charles Krupa)
December 05, 2019 - 3:43 pm
SAN DIEGO (AP) — A company that claims to have the first drug to slow mental decline from Alzheimer's disease made its case to scientists Thursday but left them sharply divided over whether there’s enough evidence of effectiveness for the medicine to warrant federal approval. Excitement and...
Read More
This undated photo provided by Acadia Pharmaceuticals Inc. shows a bottle of Nuplazid, a drug that was tested for treating psychosis related to dementia. If regulators agree, the drug could become the first treatment specifically for dementia-related psychosis and the first new medicine for Alzheimer's in nearly two decades. Results from a study on the drug were disclosed Wednesday, Dec. 4, 2019, at an Alzheimer's conference in San Diego. (Acadia Pharmaceuticals Inc. via AP)
December 04, 2019 - 8:53 pm
SAN DIEGO (AP) — A drug that curbs delusions in Parkinson's patients did the same for people with Alzheimer's disease and other forms of dementia in a study that was stopped early because the benefit seemed clear. If regulators agree, the drug could become the first treatment specifically for...
Read More
In this Aug. 14, 2019 photo provided by the University of Kentucky, Donna Wilcock, of the Sanders-Brown Center on Aging, holds a brain in her lab in Lexington, Ky. She says that contrary to popular perception, "there are a lot of changes that happen in the aging brain that lead to dementia in addition to plaques and tangles." (Mark Cornelison/University of Kentucky via AP)
September 10, 2019 - 11:00 am
WASHINGTON (AP) — Scientists are rethinking Alzheimer's disease in the wake of a string of disappointing drug failures. For years, the goal was to stop buildup of sticky plaques that are a hallmark of the mind-robbing disease. The drug flops made clear other things are playing a role, too. Now...
Read More
This microscope image shows the 46 human chromosomes, blue, with telomeres appearing as white pinpoints. Research released on Tuesday, July 16, 2019 offers some of the first biological clues to why women may be more likely than men to develop Alzheimer's disease, and how this most common form of dementia varies by gender. (Hesed Padilla-Nash, Thomas Ried/National Cancer Institute/National Institutes of Health via AP)
July 16, 2019 - 3:10 pm
LOS ANGELES (AP) — New research gives some biological clues to why women may be more likely than men to develop Alzheimer's disease and how this most common form of dementia varies by sex. At the Alzheimer's Association International Conference in Los Angeles on Tuesday, scientists offered evidence...
Read More
FILE - In this Thursday, Sept. 27, 2018 file photo, an elderly couple walks past the Berlaymont building, the European Commission headquarters, in Brussels. Research released on Sunday, July 14, 2019 suggests that a healthy lifestyle can cut the risk of developing Alzheimer's even if you've inherited genes that raise your risk for the mind-destroying disease. (AP Photo/Francisco Seco, File)
July 14, 2019 - 1:28 pm
LOS ANGELES (AP) — A healthy lifestyle can cut your risk of developing Alzheimer's or other forms of dementia even if you have genes that raise your risk for these mind-destroying diseases, a large study has found. People with high genetic risk and poor health habits were about three times more...
Read More
Democratic presidential candidate Sen. Amy Klobuchar speaks to reporters during the West Des Moines Democrats' annual picnic, Wednesday, July 3, 2019, in West Des Moines, Iowa. (AP Photo/Charlie Neibergall)
July 12, 2019 - 6:00 am
WASHINGTON (AP) — Democratic presidential candidate Amy Klobuchar (KLOH'-buh-shar) has a new plan to help seniors that includes more support for people with Alzheimer's disease and their caregivers. It's an issue that's personal for the Minnesota senator, whose 91-year-old father is in a memory...
Read More
FILE - In a May 19, 2015 file photo, R. Scott Turner, Professor of Neurology and Director of the Memory Disorder Center at Georgetown University Hospital, points to PET scan results that are part of a study on Allheimer's disease at Georgetown University Hospital, in Washington. An Alzheimer’s Association survey being released Tuesday, March 5, 2019 found about half of seniors say they’ve ever discussed thinking or memory with a health provider, and less than a third report ever getting formally assessed for cognitive problems. (AP Photo/Evan Vucci, File)
March 05, 2019 - 12:05 am
WASHINGTON (AP) — Few seniors get their thinking and memory abilities regularly tested during check-ups, according to a new report from the Alzheimer's Association that raises questions about how best to find out if a problem is brewing. Medicare pays for an annual "wellness visit" that is supposed...
Read More
Mary Radnofsky, diagnosed with a rare form of leukoencephalopathy and in the early stages of dementia, holds her service dog Benjy at her home, on Friday, Jan. 18, 2019, in Alexandria, Va. Faced with an aging American workforce, U.S. companies are increasingly navigating delicate conversations with employees suffering from cognitive declines or dementia diagnoses, experts say. (AP Photo/Kevin Wolf)
January 28, 2019 - 3:02 am
CHICAGO (AP) — Faced with an aging American workforce, companies are increasingly navigating delicate conversations with employees grappling with cognitive declines, experts say. Workers experiencing early stages of dementia may struggle with tasks they had completed without difficulty...
Read More
FILE - In this Sept. 17, 2014 file photo, retired U.S. Supreme Court Justice Sandra Day O'Connor speaks during a lecture, in Concord, N.H. O'Connor, the first woman on the Supreme Court, says she has the beginning stages of dementia and "probably Alzheimer's disease." O'Connor made the announcement in a letter Tuesday, Oct. 23, 2018. She said that her diagnosis was made "some time ago" and that as her condition has progressed she is "no longer able to participate in public life." (AP Photo/Jim Cole, File)
October 23, 2018 - 1:38 pm
WASHINGTON (AP) — Sandra Day O'Connor, the first woman on the Supreme Court, announced Tuesday in a frank and personal letter that she has been diagnosed with "the beginning stages of dementia, probably Alzheimer's disease." The 88-year-old said doctors diagnosed her some time ago and that as her...
Read More

Pages